Related Experiment Video
Updated: Mar 29, 2026

14:49
Conducting Respiratory Oscillometry in an Outpatient Setting
Published on: April 8, 2022
8.9K
Office spirometry correlates with laboratory spirometry in patients with symptomatic asthma and COPD
Gurpreet Bambra1, Leena Jalota1, Chandni Kapoor2
1Division of Pulmonary and Critical Care, University of California, San Francisco, Fresno, CA, USA. vjain@fresno.ucsf.edu.
The Clinical Respiratory Journal
|December 2, 2015
Summary
Office spirometry (OS) accurately correlates with laboratory spirometry (LS) in patients with obstructive lung disease. This finding supports routine use of OS to improve diagnosis and management of asthma and COPD.
Area of Science:
- Pulmonary Medicine
- Diagnostic Accuracy
- Respiratory Physiology
Background:
- Spirometry is crucial for diagnosing obstructive lung diseases like asthma and COPD.
- Underutilization of spirometry hinders effective patient management.
- Previous comparisons of office spirometry (OS) and laboratory spirometry (LS) focused on healthy individuals.
Purpose of the Study:
- To assess the correlation between OS and LS in patients with symptomatic obstructive lung disease.
- To determine the accuracy and reliability of OS compared to LS in this specific patient population.
Main Methods:
- Retrospective analysis of spirometry data from 107 patients with obstructive lung disease who underwent both OS and LS.
- Comparison of data using Bland Altman analysis.
- Utilized two types of flow-sensing portable spirometers for OS.
Main Results:
- Significant positive correlation found between OS and LS for FEV1 (r=0.937) and FVC (r=0.90).
- 87% of patients showed concordant results regarding airflow obstruction.
- Correlation was consistent across different office spirometer devices.
Conclusions:
- Office spirometry (OS) is an accurate and reliable tool for evaluating patients with asthma and COPD.
- Routine implementation of OS can enhance spirometry utilization and improve patient health outcomes.
- Encouraging OS use can lead to better management of obstructive lung diseases.

